Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
Impaired glucagon secretion in patients with diabetes causes hypoglycemia. Here the authors show that therapeutic concentrations of insulin inhibit alpha-cell glucagon secretion by stimulating delta-cell insulin receptor and the release of somatostatin. Blocking somatostatin secretion or action amel...
Guardado en:
Autores principales: | Elisa Vergari, Jakob G. Knudsen, Reshma Ramracheya, Albert Salehi, Quan Zhang, Julie Adam, Ingrid Wernstedt Asterholm, Anna Benrick, Linford J. B. Briant, Margarita V. Chibalina, Fiona M. Gribble, Alexander Hamilton, Benoit Hastoy, Frank Reimann, Nils J. G. Rorsman, Ioannis I. Spiliotis, Andrei Tarasov, Yanling Wu, Frances M. Ashcroft, Patrik Rorsman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d4aeee6ff1d49cdae2f6687f5fe8637 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
α-cell glucokinase suppresses glucose-regulated glucagon secretion
por: Davide Basco, et al.
Publicado: (2018) -
Basal hypersecretion of glucagon and insulin from palmitate-exposed human islets depends on FFAR1 but not decreased somatostatin secretion
por: H. Kristinsson, et al.
Publicado: (2017) -
Adenosine triphosphate is co-secreted with glucagon-like peptide-1 to modulate intestinal enterocytes and afferent neurons
por: Van B. Lu, et al.
Publicado: (2019) -
Somatostatin Receptors in Human Meningiomas—Clinicopathological Aspects
por: Sofie Eline Tollefsen, et al.
Publicado: (2021) -
Somatostatin and Its Receptor System in Colorectal Cancer
por: Aldona Kasprzak
Publicado: (2021)